Peak6 LLC Intellia Therapeutics, Inc. Call Options Transaction History

Peak6 LLC

  • $61.1 Billion
  • Q3 2025

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$9.88 - $17.76 $1.87 Million - $3.37 Million
189,500 Added 122.73%
343,900 $5.94 Million
Q2 2025

Aug 13, 2025
BUY
$6.28 - $9.67 $273,180 - $420,645
43,500 Added 39.22%
154,400 $1.45 Million
Q1 2025

May 14, 2025
BUY
$7.11 - $12.8 $256,671 - $462,080
36,100 Added 48.26%
110,900 $788,000
Q4 2024

Feb 13, 2025
BUY
$11.41 - $21.09 $853,468 - $1.58 Million
74,800 New
74,800 $872,000

Others Institutions Holding NTLA

# of Institutions
343
Shares Held
103M
Call Options Held
3.16M
Put Options Held
1.56M
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $661M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Peak6 LLC Portfolio

Follow Peak6 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email